Search results
Pfizer's Nearly $7 Billion Acquisition Of Arena Pharma Just Paid Off In A Big Way
Investor's Business Daily· 2 years agoPfizer's nearly $7 billion takeover of Arena Pharmaceuticals looked prescient Tuesday after the...
Pfizer's (PFE) Ulcerative Colitis Pill Etrasimod Gets FDA Nod
Zacks via Yahoo Finance· 7 months agoPfizer PFE announced that the FDA has granted approval to its oral, once-daily pill called etrasimod...
Pfizer Is Proving Itself in a Tough Post-Covid Scenario
GuruFocus.com via Yahoo Finance· 2 years agoIn 2021, Pfizer Inc. (NYSE:PFE) succeeded with its coronavirus vaccine, leading to a substantial...
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
Motley Fool· 5 months agoPfizer's (NYSE: PFE) stock performance has been disappointing this year (down 38%). For example,...
Why Pfizer Likely Isn't Done With M&A After the Seagen Deal
Motley Fool· 1 year agoPfizer (NYSE: PFE) has been a company on a mission, looking to restock its pipeline with growth...
Where Will Pfizer Be in 10 Years?
Motley Fool via Yahoo Finance· 3 months agoPfizer (NYSE: PFE) has reached a major transition point. The big pharma company took center stage earlier in the COVID-19 pandemic when it became the...
Is Pfizer Stock a Buy in 2024?
Motley Fool via Yahoo Finance· 4 months agoIf you're in the process of rebalancing your portfolio, you might be considering buying Pfizer (NYSE: PFE) stock. After all, the drugmaker pays a...
Pfizer is buying a cancer biotech in one of the biggest pharma deals in history
Quartz via Yahoo Finance· 1 year agoPharmaceutical giant Pfizer is buying Seagen, a biotech company making a novel type of cancer...
Pfizer's Ulcerative Colitis Candidate Shows Remission In Over 30% Of Patients In Pivotal Studies
Benzinga via Yahoo Finance· 2 years agoPfizer Inc (NYSE: PFE) has announced detailed results from two pivotal studies from ELEVATE UC Phase...
Does This Billion-Dollar Deal Solve Pfizer's Biggest Problem?
Motley Fool· 1 year agoPfizer (NYSE: PFE) brought in more than $100 billion in revenue last year -- a record. But investors...
